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Abstract
Background: Pediatric human immunodeficiency virus (HIV) infection is still an important public health issue despite 
a decrease in global, national, and local seroprevalence rates.
Design: A prospective, hospital‑based study was conducted.
Materials and Methods: One‑hundred and sixty children presenting for the first time to the hospital were studied. Each child 
had a detailed physical examination and initial double rapid HIV antibody tests. A virological confirmatory test was done for 
those aged less than 18 months of age with positive results. Mothers of HIV‑infected children also had HIV testing. HIV‑infected 
children were enrolled into HIV care and followed up for 6 months. Data were analyzed using the SPSS 16.0 for Windows.
Results: Twenty‑two (13.8%) children were confirmed HIV‑infected. The mean age was 26.9 ± 30.8 months. Male to 
female ratio was 1.1:1. Probable modes of transmission were mother‑to‑child in 63.6%, group circumcision in 22.7%, 
sexual transmission in 9.1% and unscreened blood transfusion in 4.5%. The most frequent symptoms on presentation 
were fever in 95.4% of patients, cough and weight loss in 77.3% and diarrhoea in 59.1%. The most common signs were 
hepatomegaly in 77.3%, pyrexia and crepitations in 72.7%, and pallor in 40.9%. Commonly diagnosed conditions were 
undernutrition, diarrheal disease, oral thrush, and pneumonia. Tuberculosis co‑infection was diagnosed in 18.2% of 
children. Fourteen (63.6%) children had advanced and severe immunodeficiency. Mortality rate over 6 months was 18.2%.
Conclusion: Early diagnosis of pediatric HIV and prompt institution of treatment in children would go a long way in 
reducing the scourge of the disease.
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Majority of  children infected with the human 
immunodeficiency virus are living in sub‑Saharan Africa.[1] 
While global figures are on the decline, the numbers of children 
living with and dying of the human immunodeficiency virus 
(HIV) infection are on the increase in Nigeria.[1,2] The 
number of children living with HIV in Nigeria increased 
from 220 000 in 2007 to 360 000 by the end of 2009.[2] There 
were 220 000 deaths due to HIV at the end of 2009,[1] an 
increase from 170 000 at the end of 2007.[2]
When infected with HIV, children present with a wide 
spectrum of clinical presentations ranging from asymptomatic 
HIV infection to acquired immunodeficiency syndrome 
(AIDS), characterized by severe immunosuppression. 
Predominant presentations include respiratory infections, 
malnutrition, diarrhea, and septicemia.[3‑7]
This study was undertaken to determine the prevalence, 
clinical features and CD4+ counts plus percentage, and 
mortality rate of pediatric HIV infection in the region.
Materials and Methods
Consecutive children aged between 2 months and 15 years 
presenting for the first time to the pediatric out‑patient 
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clinic and emergency pediatric unit of the hospital between 
June and August 2010 were screened for enrolment. 
Inclusion criteria were children whose caregivers provided 
informed consent. Children with known HIV infection were 
excluded. Ethical approval was obtained from the Ethics 
committee of the hospital.
Each enrolled child had a complete physical examination 
and an initial double rapid HIV test in parallel using 
the DetermineTM (by ABBOTT Japan Co., Ltd., LOT 
80610U100) and UnigoldTM (by Trinity Biotech Plc., LOT 
T078027) HIV test kits. Those who tested positive to both 
test kits had blood drawn for further tests including HIV DNA 
PCR, complete blood counts, CD4 percentages (preferred 
immunologic marker for monitoring HIV disease progression 
in children under 5 years[8]) and CD4 counts (for children 
5 years and above). Partec CyFlow counter, serial number 
050117117 was used for the estimation of the CD4 count 
and CD4% while applied biosystems model 9700 was 
used for HIV DNA PCR in children less than 18 months. 
Mothers of HIV‑positive children were also screened for 
HIV infection. Children with HIV infection were placed 
on trimethoprim‑sulfamethoxazole prophylaxis and enrolled 
into an on‑going, comprehensive HIV/AIDS care, and 
treatment program at the special treatment clinic at the 
study center. Further tests were carried out on the children 
depending on the suspected clinical condition, and these 
tests included chest X‑rays, serum chemistries as well as 
microbiological studies on blood, cerebrospinal fluid, and 
urine. Children who required admission were admitted and 
managed according to established standards of care, and on 
discharge, HIV‑infected children were followed up at the 
special treatment clinic while the uninfected children were 
followed up at the pediatric out‑patient clinic.
Data obtained were analyzed using the SPSS software 
version 16.0 for Windows. Means, median, and percentages 
were calculated where appropriate. Results were presented 
in tables and figures. Categorical variables were compared 
using either the Chi‑square test or Fisher’s exact test while 
continuous variables were analyzed using the Student’s 
t‑test or analysis of variance. Statistical significance level 
was set at P < 0.05.
Results
One‑hundred and sixty children comprising 87 males 
and 73 females were enrolled into the study. The age and 
gender distribution of the subjects are shown in [Table 1]. 
The male:female ratio was 1.1:1. The mean age was 
26.9 ± 30.8 months. Eighty‑nine percent of the children 
were less than 5 years of age, with those less than 2 years 
comprising 60% of these. Twenty‑two (13.8%) children were 
confirmed positive for HIV infection. Of those confirmed, 
18 (81.8%) were less than 5 years of age while 12 (54.4%) 
were less than 2 years.
Mother‑to‑child transmission of HIV was the probable mode 
of transmission in 14 (63.6%) of the HIV‑infected children, 
with non‑vertical transmission accounting for 36.4%. The 
probable modes of transmission in the HIV‑infected children 
included are shown in [Figure 1].
The clinical presentation of the subjects is presented 
in [Table 2]. Fever was found in 21 (95.4%) children, cough 
in 17 (77.3%), and weight loss in 17 (77.3%). The skin 
lesions seen in the HIV‑infected children were seborrhoeic 
dermatitis and extensive tinea corporis. The neurological 
manifestations included delayed developmental milestones, 
microcephaly, convulsions, and coma. Two children (9.1%) 
had abdominal pain with foul‑smelling vaginal discharge 
on presentation. Seventeen (77.3%) of the HIV‑infected 
children had more than one symptom/sign at presentation.
[Table 3] shows the associated illnesses found in the 
HIV‑infected subjects. Seventeen (77.3%) of the 
HIV‑infected children had more than one co‑morbid 
condition at presentation. Undernutrition and diarrheal 
disease were the commonest associated morbidities found 
in 17 (77.3%) and 15 (68.2%) children, respectively. Other 
Table 1: Age and gender distribution of the subjects
Age group (months) Male n (%) Female n (%) Total n (%)
2-<12 29 (18.1) 29 (18.1) 58 (36.2)
12-<24 20 (12.5) 18 (11.2) 38 (23.8)
24-<36 16 (10.0) 16 (10.0) 32 (20.0)
36-<48 6 (3.8) 3 (1.9) 9 (5.6)
48-<60 5 (3.1) 0 (0.0) 5 (3.1)
60-<120 8 (5.0) 3 (1.9) 11 (6.9)
120-180 3 (1.9) 4 (2.5) 7 (4.4)
Total 87 (54.4) 73 (45.6) 160 (100)
Table 2: Clinical features found in the HIV‑infected 
subjects
Clinical feature Number (%)
Fever 21 (95.4)
Cough 17 (77.3)








Neurological manifestations 8 (36.4)
Parotid fullness 8 (36.4)
Oral sores 7 (31.8)
Skin manifestations 6 (27.3)
Vaginal discharge 2 (9.1)
*Most children had more than one clinical feature on presentation, 
HIV=Human immunodeficiency virus
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diagnoses in the HIV‑infected children included pneumonia, 
septicemia, disseminated tuberculosis, and meningitis in 
40.9, 31.8, 18.2, and 13.6%, respectively.
The mean CD4 counts and percentages of the HIV‑infected 
children in different age groups are shown in [Table 4]. The 
mean CD4 percent for all children was 21.95 ± 7.4 while it 
was 20.55 ± 4.8 for children under 5 years of age. [Table 5] 
shows the comparison between the immunological 
parameters and the WHO clinical stage in the HIV‑infected 
children. Fourteen (63.6%) children were in advanced and 
severe stages of immunodeficiency.
The mortality pattern in the study population after 
6 months of follow up is shown in [Table 6]. Four (18.2%) 
of the 22 HIV‑infected children died compared to 
3 (2.2%) uninfected children and this was statistically 
significant (P = 0.001).
Discussion
Most reported studies on pediatric HIV in Nigeria were either 
retrospective or done on children with clinical signs suggestive 
of HIV infection, thereby giving seroprevalence rates which 
differ widely.[3‑7] However, a prospective study by Ogunbosi 
et al.[6] in 2008 in consecutive children presenting at the 
University College Hospital, Ibadan, showed a HIV prevalence 
rate of 10% which is only slightly lower than the 13.8% 
observed in this study. This study, though also hospital‑based, 
reiterates the fact that HIV infection is still a significant public 
health issue in children and the figures indicate a need for more 
preventive efforts in combating the disease in this country.
The age distribution of pediatric HIV in this study did not 
differ much from what was obtained in previous studies Table 3: Associated conditions in HIV‑infected patients
Associated illness Number (%)
Undernutrition 17 (77.3)
Diarrhoeal disease 15 (68.2)
Pneumonia 9 (40.9)
Septicemia 7 (31.8)
Disseminated tuberculosis 4 (18.2)
Meningitis 3 (13.6)
Chronic suppurative otitis media 2 (9.1)
Sexually transmitted infection 2 (9.1)
Malaria 1 (4.5)
Measles 1 (4.5)
*Most children had more than one associated illness, HIV=Human 
immunodeficiency virus
Table 4: Mean CD4 counts and CD4% of HIV‑positive 









0-<12 8 (36.4) 1465±777 22.1±7.9
12-<24 4 (18.2) 650±308 16.5±7.2
24-<36 3 (13.6) 885±264 22.7±4.2
36-<48 2 (9.1) 650±229 18.0±5.7
48-<60 1 (4.5) 1020 24.0 
60-<120 2 (9.1) 584±404 24±11.3
120-<180 2 (9.1) 1547±104 32±1.4
Total 22 (100) 1071±626 21.95±7.4
HIV=Human immunodeficiency virus
Table 5: Comparison between immunological parameters and WHO clinical stage in HIV‑infected children
Variables n (%) Mean CD4 count±SD Mean CD4%±SD WHO classification of immunodeficiency (%)
NS Mild Advanced Severe
Clinical stage
1 6 (27.3) 1491±470 31.0±2.2 3 (50) 2 (33.3) 1 (16.7) 0 (0.0)
2 3 (13.6) 1577±811 26.8±4.1 0 (0.0) 2 (66.7) 1 (33.3) 0 (0.0)
3 4 (18.2) 892±431 22.0±3.9 0 (0.0) 1 (25.0) 2 (50.0) 1 (25.0)
4 9 (40.9) 631±346 14.3±3.6 0 (0.0) 0 (0.0) 2 (22.2) 7 (77.8)
NS=Not significant immunodeficiency, HIV=Human immunodeficiency virus, WHO=World Health Organization
Table 6: Mortality pattern in study population
Mortality 
status
HIV Status Total P OR (95% CI)
Positive Negative
Died 4 (18.2%) 3 (2.2%) 7 0.001 10.0 (2.07,48.34)
Survived 18 (81.8%) 135 (97.8%) 153
Total 22 138 160









Figure 1: Pie chart depicting probable modes of HIV transmission 
in HIV‑positive patients
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with younger children more commonly affected.[3‑5,7] The 
finding may be explained by the more rapid progression of 
HIV disease in younger children.[9]
Vertical transmission is the commonest reported route 
of transmission of HIV in children worldwide. In this 
study, this route accounted for 63.6% of HIV infection 
in children which is much lower than the documented 
rates of over 90%.[1,2] Recent reports have emphasized the 
importance of non‑vertical transmission of HIV especially in 
older children,[10‑12] and this is corroborated by the findings 
in this study. However, the high prevalence of vertical 
transmission still emphasizes the need for strengthening of 
programs geared toward the prevention of mother‑to‑child 
transmission of HIV infection. In the developed world, 
efforts at preventing HIV infection in women of childbearing 
age and prevention of mother‑to‑child transmission have 
resulted in dramatic declines in the rates of HIV infection 
in children.[13,14]
Of note was the finding that, in this study, HIV transmission 
occurred probably via group circumcision in five infected 
boys (22.7%). Their mothers had tested negative to HIV 
and none of them had received blood transfusion previously. 
Three of the five boys had circumcision performed at the same 
time by a local barber, known as a ‘‘wanzami,’’ while the other 
two boys had theirs done in other groups. Circumcision, being 
a religious obligation among Muslims, is a common practice 
in Northern Nigeria. However, the practice of carrying it out 
on groups of young boys, by a local barber, using one knife 
is a major public health problem as it increases the risk of 
transmission of other blood‑borne diseases, as well as profuse 
bleeding which can be fatal. There is documented evidence 
for widespread unsterile procedures in African medical 
settings and non‑vertical infections in African children[15] and 
the risks have been highlighted by several authors.[15,16] This 
calls for new initiatives to improve our health information 
system as well as to strengthen infection control in formal 
and informal health care settings.
Sexual transmission is believed to have accounted for 9.1% 
of modes of transmission of HIV in this study. This was 
found in girls who had reportedly been sexually abused and 
had presented with clinical symptoms and signs suggestive 
of sexually transmitted infections. Children in primary and 
secondary schools may experiment with sex and are at 
risk of sexual exploitation and molestation. Thus, in areas 
where there is early sexual debut, low rates of condom use 
and high HIV prevalence rates, as obtained in this study 
area, sexual abuse should be considered as a possible risk 
for HIV transmission.[17]
This study found a low rate of transfusion‑related transmission 
of HIV of 4.5%. When compared to other studies, the results 
of this study may be a reflection of the improvement in our 
blood safety practices, as can be seen in countries where strict 
blood safety practices are enforced.[18,19] Blood transfusion as a 
possible mode of HIV transmission was found in a 60 month 
old, uncircumcised boy, who had blood transfusion in a private 
hospital on account of severe anaemia. Both parents had 
tested negative to HIV and the boy had never been transfused 
prior to the reported incident.
The clinical features which were suggestive of HIV infection 
were persistent diarrhea, chronic cough, prolonged fever, 
weight loss/poor weight gain, oral thrush, significant lymph 
node enlargement, hepatosplenomegaly, recurrent ear 
discharge, and parotid fullness. A previous report from this 
study area also documented similar findings.[20] This was 
in conformity with results from elsewhere,[3‑5,21] and have 
been included in the World Health Organization major and 
minor clinical manifestation of pediatric HIV/AIDS in the 
African setting.[22] In this study, the features which were 
significantly predictive of HIV infection were persistent 
diarrhoea, weight loss/poor weight gain, recurrent ear 
discharge, and parotid fullness.
Neurologic manifestations were seen in as many as 22.7% 
of HIV‑infected children in this study. The significance 
of neurologic manifestations of HIV infection in children 
has been highlighted by Tardieu et al.[23] in France where 
they found that the highest incidence of HIV‑associated 
CNS disease occurs in the first 2 years of life in 30‑60% of 
HIV‑infected children, and this can occur independently of 
systemic HIV disease in 12% of cases. HIV readily invades the 
immature brain causing static or progressive encephalopathy. 
Majority of the children in this study were in this age group.
Protein‑energy malnutrition is a common clinical syndrome 
associated with pediatric HIV, with marasmus being the 
most common form as reported in several studies.[5,24] In 
this study, 77.3% of HIV‑infected children had evidence 
of undernutrition. Marasmus was seen in 45.5% of the 
subjects while 9.1% had kwashiorkor. The pattern of growth 
failure among the children in this study shows that there is 
a relatively high prevalence of acute (underweight of low 
weight‑for‑age) and chronic (stunting or low height‑for‑age) 
growth failure in HIV‑infected. Targeted nutritional 
interventions in HIV‑infected children may therefore have 
a significant impact in pediatric HIV care programs.
Respiratory tract infections are commonly found in 
HIV‑infected children. In this study, 59.1% of HIV positive 
children had features of pneumonia on presentation. Of 
these, a diagnosis of bronchopneumonia was made in 40.9% 
and disseminated tuberculosis in 18.2%. This corroborates 
the findings in studies from other parts of the country,[3‑5] 
with higher rates of tuberculosis co‑infection documented 
in studies from India and Sudan.[9,25,26] However, reports 
from Africa have consistently shown that respiratory 
conditions are a major cause of morbidity and mortality 
among HIV‑infected children.[3‑5,9,27]
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Children in this study, especially those under 5 years of age, 
had advanced disease as indicated by their clinical features, 
severe malnutrition, and profound immunosuppression on 
presentation. These children may have presented to other 
health facilities at different times and received treatment for 
various conditions without having been screened for HIV 
infection. This highlights the need for routine screening 
for HIV in our health facilities so as to prevent delayed 
diagnosis of HIV disease.
The mortality rate among HIV‑infected children in 
this study was 18.2%. All the mortality was observed in 
children less than 24 months of age who were severely 
undernourished. This is similar to findings by other 
authors.[3,4] Undernutrition may be a direct consequence of 
the HIV infection, particularly from diarrhoea and anorexia 
resulting from the HIV disease. It may also be as a result 
of repeated infections, a function of the child’s adverse 
environment, or a combination of all these factors leading 
to higher mortality. Therefore, strategies aimed at reducing 
infections in children such as routine immunization, 
improved socio‑economic status, and improved nutrition 
should be strengthened and encouraged at all levels.
The burden of pediatric HIV/AIDS continues to impact 
negatively on our society. It is a major contributor to 
childhood morbidity and mortality, and early pediatric HIV 
diagnosis can reduce the poor outcomes in children. Prompt 
institution of therapy for HIV‑infected children improves 
their outcomes. Health education, health promotion 
strategies, sustainable, and free availability of antiretroviral 
medications are ways through which adult HIV infection 
rates can be reduced, with the consequence of reduction 
in childhood HIV infection. Therefore, programs geared 
toward the prevention of mother‑to‑child transmission of 
HIV infection, which has been documented as the most 
common mode of HIV transmission, should be emphasized, 
and scaled up. There is the need to strengthen advocacy 
for the protection of children against harmful practices like 
group circumcision and sexual abuse which still occur in 
our society. Routine screening of blood before transfusion 
should continually be enforced especially in private settings. 
The Nigerian government and other stakeholders need to 
appreciate the need for drastic measures to be taken to 
combat pediatric HIV/AIDS.
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